PT Diagnos Laboratorium Utama Tbk

IDX:DGNS.JK

246 (IDR) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) IDR.

2023202220212020201920182017
Operating Activities:
Net Income -13,655.80612,664.8964,303.50652,686.5389,274.5919,264.7531,381.911
Depreciation & Amortization 14,634.29913,234.5327,561.7763,841.9422,255.613409.37149.614
Deferred Income Tax 0000000
Stock Based Compensation 0000000
Change In Working Capital 0000000
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0000000
Other Working Capital 0000000
Other Non Cash Items 12,205.08-5,446.2812,133.179-22,616.1254,177.356-387.282-2,044.302
Operating Cash Flow 13,183.573-6,015.92358,874.90826,228.47111,196.3348,468.099-712.005
Investing Activities:
Investments In Property Plant And Equipment -38,324.419-34,852.993-67,841.033-5,863.648-2,782.305-3,836.704-327.481
Acquisitions Net 649.65000000
Purchases Of Investments -4,506-8,051.30700000
Sales Maturities Of Investments 4,064.35000000
Other Investing Activites -4,064.3525,354.115-7,726.529-2,286.777-26,456.857-2,625.452-709
Investing Cash Flow -42,388.769-17,550.184-75,567.562-8,150.425-29,239.162-6,462.156-1,036.481
Financing Activities:
Debt Repayment -11,439.424-10,773.1-4,253.98-369.847-5,096.09-112.8050
Common Stock Issued 0049,477.995024,75000
Common Stock Repurchased 00-646.260000
Dividends Paid 00-6,0000000
Other Financing Activities -2,041.976-714.5956,296.485-30,424.42624,750-1,659.2471,757.01
Financing Cash Flow 11,439.4246,856.9344,874.239-2,933.16917,898.889-1,772.0521,757.01
Other Information:
Effect Of Forex Changes On Cash 000-0001,294.917
Net Change In Cash -17,765.773-16,709.17728,181.58615,144.877-143.939233.8911,303.442
Cash At End Of Period 10,244.90628,010.67944,719.85616,538.271,393.3931,537.3331,303.442